Janssen Biotech, Inc
For Grant Instructions, Policies and Guidelines, click here.
To access the electronic grant application system, click here.
At Janssen Biotech, we harness innovations in large-molecule and small-molecule compounds to create important new therapeutic options. Beyond innovative medicines, we are also committed to programs that ensure patients, caregivers, advocates, and healthcare professionals have access to the latest treatment information and support services.

Educational grants and fellowships are provided for specific educational purposes that benefit patients and healthcare professionals in the following therapeutic areas:
  • Dermatology
  • Gastroenterology
  • Oncology
  • Rheumatology
  • Janssen Biotech will be accepting requests for support of satellite symposia at ASH 2015 until February 15, 2015
  • Janssen Biotech will be accepting requests for support for satellite symposia at ASCO 2015 until March 8, 2015
Janssen Scientific Affairs, LLC
For Grant Instructions, Policies and Guidelines, click here.
To access the electronic grant application system, click here.
Janssen Scientific Affairs, LLC is committed to improving patient care in our disease states of interest through support of independent educational grants for activities targeting healthcare providers, fellows, and patients/caregivers.

Educational grants and fellowships are provided for specific educational purposes that benefit patients and healthcare professionals in the following therapeutic areas:
  • Thrombosis (DVT/PE Treatment, Stroke Prevention in Atrial Fibrillation, Acute Coronary Syndrome, General Thrombosis and Anticoagulation)
  • Psychiatry (Schizophrenia/Schizoaffective Disorder - Evidence-based treatment, Care Coordination, Quality Measures, Patient Recovery)
  • Metabolism: T2DM educational areas of interest include The Pathophysiology of T2DM Including the Role of the Kidney in Glucose Homeostasis; New Therapies for T2DM; Treatment Guidelines for T2DM; HEDIS, STARS, P4P, ACA & T2DM; and, Patient Engagement. The proposed Target audiences include PCP, PAs, NPs and other HCPs.

Current funding availability:
  • Schizophrenia/Schizoaffective Disorder - Funding Available.
  • Type 2 Diabetes - Small Grants Accepted.
  • DVT/PE Treatment - Small Grants Accepted.
  • Stroke Prevention in Afib - Small Grants Accepted.
  • ACS – Small Grants Accepted.
  • General Thrombosis and Anticoagulation – Small Grants Accepted.

We are not accepting applications for general support of the following regularly scheduled activities:
  • Professional Society annual meetings, special interest conferences, sponsored regional series, or other regularly scheduled Society- sponsored meetings
  • Single- or half-day regional update conferences Disease state-specific educational activities held in conjunction with these regularly scheduled meetings may be considered.

Janssen Therapeutics, Division of Janssen Products, LP
For Grant Instructions, Policies and Guidelines, click here.
To access the electronic grant application system, click here.
Janssen Therapeutics strives to be a leader in the field of virology by supporting relevant, innovative, and quality education that enhances understanding of virology therapeutics and improves the lives of people with HIV and Hepatitis C. We are committed to supporting educational programs for patients and healthcare professionals that are aligned with our vision and our areas of interest.

Educational grants and fellowships are provided for specific educational purposes that benefit patients and healthcare professionals in the following therapeutics areas:
  • HIV/AIDS
  • Hepatitis C